Exact Mass: 218.1505
Exact Mass Matches: 218.1505
Found 146 metabolites which its exact mass value is equals to given mass value 218.1505,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
5-Methoxydimethyltryptamine
5-Methoxydimethyltryptamine, like all methoxydimethyltryptamines is a compound that contain the biogenic monoamine tryptamine and is substituted with one methoxy group and two methyl groups. Members of this group include several potent serotonergic hallucinogens found in several unrelated plants, skins of certain toads, and in mammalian brains. They are possibly involved in the etiology of schizophrenia. They are formed as metabolites of serotonin (5-hydroxytryptamine) or tryptamine by the enzyme indolethylamine N-methyltransferase (INMT). The physiological significance of the N-methylating pathway of indoleamine metabolism, and of the methylated end products, is unknown. Because of the known psychotropic properties of the dimethylated amines, their possible involvement in the chemical pathogenesis of mental disorders has received wide interest. The hallucinogenic actions of the methylated indoleamines, like those of LSD, are believed to be mediated through the 5HT2 receptor. (PMID 11763413). 5-Methoxydimethyltryptamine, like all Methoxydimethyltryptamines is a compound that contain the biogenic monoamine tryptamine and is substituted with one methoxy group and two methyl groups. Members of this group include several potent serotonergic hallucinogens found in several unrelated plants, skins of certain toads, and in mammalian brains. They are possibly involved in the etiology of schizophrenia. (PubChem) C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist KEIO_ID M103; [MS2] KO009040 KEIO_ID M103
N-despropyl ropinirole
N-despropyl ropinirole is a metabolite of ropinirole. Ropinirole (INN; trade names Requip, Ropark, Adartrel) is a non-ergoline dopamine agonist. It is manufactured by GlaxoSmithKline (GSK), Cipla and Sun Pharmaceutical. It is used in the treatment of Parkinsons disease. Ropinirole is one of three medications approved by the FDA to treat Restless Leg Syndrome, the other two being pramipexole (Mirapex) and gabapentin enacarbil (Horizant). The discovery of the drugs utility in RLS has been used as a successful example of drug repurposing. (Wikipedia)
2,3-Dihydroxypropyl octanoate
C78276 - Agent Affecting Digestive System or Metabolism
1,8-Dimethyl-3a-methoxy-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole
Eseroline
A pyrroloindole that is 1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole substituted by methyl groups at positions 1, 3a and 8 and a hydroxy group at position 5. It is a metabolite of physostigmine and causes neuronal cell death by a mechanism involving loss of cell ATP. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics CONFIDENCE standard compound; EAWAG_UCHEM_ID 3583
2-Phenylpiperidine-2-acetamide
CONFIDENCE standard compound; EAWAG_UCHEM_ID 3584
(-)-Eseroline
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.272
1-carboxy-1-(trimethyl-l4-azaneyl)-4-ureidobutan-1-ylium
1-(3-DIMETHYLAMINO-PROPYL)-1H-BENZOIMIDAZOL-2-YLAMINE
3-Amino-3-fluoromethyl-pyrrolidine-1-carboxylic acid tert-butyl ester
1-(3-acetyl-2,4-dihydroxy-6-methoxyphenyl)ethan-1-one
4-CHLORO-7-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-7H-PYRROLO[2,3-D]PYRIMIDINE
(1S,4S)-(+)-2-(2-CHLORO-BENZYL)-2,5-DIAZA-BICYCLO[2.2.1]HEPTANEDIHYDROCHLORIDE
2-[5-ethyl-5-(hydroxymethyl)-1,3-dioxan-2-yl]-2-methylpropan-1-ol
4,4,5,5-Tetramethyl-2-(m-tolyl)-1,3,2-dioxaborolane
2H-Azepin-2-one, hexahydro-3-[(phenylmethyl)amino]-, (3R)
(4S)-4-tert-butyl-2-(6-methylpyridin-2-yl)-4,5-dihydro-1,3-oxazole
1-(3,4-DIHYDRO-2H-[1,8]NAPHTHYRIDIN-1-YL)-2,2-DIMETHYL-PROPAN-1-ONE
Fenoxazoline
R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AA - Sympathomimetics, plain C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist
2-Oxa-6-azaspiro[3.4]octan-8-amine, 6-(phenylmethyl)-
4,4,5,5-Tetramethyl-2-(2-methylphenyl)-1,3,2-dioxaborolane
4-Amino-2-fluoromethyl-pyrrolidine-1-carboxylic acid tert-butyl
1,3-Di-tert-butyl-1,3,2-diazaphospholidine 2-Oxide
N-(3-ALLYL-PYRIDIN-2-YL)-2,2-DIMETHYL-PROPIONAMIDE
1-(7-amino-4,4-dimethyl-1,3-dihydroisoquinolin-2-yl)ethanone
(3R,4R)-tert-Butyl4-amino-3-fluoropiperidine-1-carboxylate
10-methoxy-2,3,4,6,7,11b-hexahydro-1H-pyrazino[2,1-a]isoquinoline
9-methoxy-2,3,4,6,7,11b-hexahydro-1H-pyrazino[2,1-a]isoquinoline
tert-butyl N-[(3R,4R)-4-fluoropiperidin-3-yl]carbamate
3,9-Diazaspiro[5.5]undecan-2-one, 3-ethyl-, hydrochloride (1:1)
4,4,5,5-Tetramethyl-2-(p-tolyl)-1,3,2-dioxaborolane
tert-butyl 4-amino-3-fluoropiperidine-1-carboxylate
2-methyl-N-[4-(propan-2-ylamino)phenyl]-2-propenamide
gamma-L-glutamylputrescinium(1+)
Conjugate acid of gamma-L-glutamylputrescine.
(3aS,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-ol
(3R)-3,11-dihydroxyundecanoic acid
A dihydroxy monocarboxylic acid that is 11-hydroxyundecanoic acid in which the pro-R hydrogen beta to the carboxy group is replaced by a hydroxy group.
(3R,10R)-3,10-dihydroxyundecanoic acid
An (omega-1)-hydroxy fatty acid that is (10R)-10-hydroxyundecanoic acid in which the 3-pro-R hydrogen is replaced by a hydroxy group.
1-carboxy-1-(trimethyl-l4-azaneyl)-4-ureidobutan-1-ylium
5-Methoxydimethyltryptamine
C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist
Ala-Lys(1+)
A peptide cation obtained by deprotonation of the carboxy terminus and protonation of the side-chain amino groups and the amino terminus of Ala-Lys; major species at pH 7.3.
5-Methoxy-N,N-dimethyltryptamine
A tryptamine alkaloid that is N,N-dimethyltryptamine substituted by a methoxy group at position 5.
RO5256390
RO5256390 is an agonist of trace amine-associated receptor 1 (TAAR1), a highly conserved G-protein-coupled receptor (GPCR) bound by endogenous trace amines. RO5256390 can be used to reduce multiple behavioral effects of agents of abuse through their actions on the mesocorticolimbic system[1]. RO5256390 is a modulator of monoaminergic neurotransmission, blocks psychostimulant-induced hyperactivity and produces a brain activation pattern reminiscent of the antipsychotic agent olanzapine, suggesting antipsychotic-like properties[2].
